Maiken Keson-Brookes is chief legal officer for Mural Oncology.
Prior to Mural, Ms. Keson-Brookes served as chief legal officer and corporate secretary of Rubius Therapeutics Inc., a cell therapy company, where she had responsibility for all corporate legal, intellectual property and securities matters and was a member of the executive team. Previously, Ms. Keson-Brookes held senior legal positions at Synlogic, Inc., uniQure, and Forum Pharmaceuticals, where she established the company’s first legal department and built a legal team to support all aspects of the business. Earlier in her career, Ms. Keson-Brookes held legal roles at Genzyme and Biogen. While with Biogen, Ms. Keson-Brookes served as attorney for the ex-U.S. launch of several products and provided legal oversight for the Company’s manufacturing group, including a large-scale manufacturing facility construction project.
Ms. Keson-Brookes holds master of laws and bachelor of laws degrees from King’s College University of London.